Sabra Health Care REIT stock stood at EUR 17.25

Sabra Health Care REIT stock was last at EUR 17.25 on TradeGate on September 25, 2026. The latest operating picture combines higher revenue with a quarterly earnings miss, while management's 2026 funds-from-operations guidance remains central to the valuation discussion.

Revenue rose by 24.70 percent

Sabra reported Q2 2026 revenue of USD 230.11 million, up 24.70 percent from the same quarter a year earlier, according to MarketBeat in its September 25, 2026 report. Revenue also exceeded the USD 219.39 million consensus cited in the same report, a USD 10.72 million difference.

The earnings line moved in the opposite direction. Adjusted EPS was a loss of USD 0.10 in Q2 2026 against consensus EPS of USD 0.17, while the prior-year quarter had produced EPS of USD 0.38, according to MarketBeat.

FFO guidance frames the outlook

Sabra's September 9, 2026 investor presentation carried 2026 guidance of USD 1.53 to USD 1.55 for normalized FFO per diluted share and USD 1.58 to USD 1.60 for AFFO. The same presentation described midpoint growth of 7.00 percent for normalized FFO and 8.00 percent for normalized AFFO, according to MarketScreener.

The guidance separates recurring cash generation from the volatility visible in GAAP earnings. Sabra also reported 395 investments and 61 operator relationships as of June 30, 2026, with skilled nursing and transitional care representing 47.70 percent of annualized cash NOI in the presentation.

Analyst target remains above Nasdaq price

MarketBeat reported a Moderate Buy consensus from 14 brokerages on September 25, 2026, split between seven buy ratings and seven hold ratings. The average 12-month target was USD 22.23, compared with a Nasdaq price of USD 19.77 cited in that report, leaving a USD 2.46 target difference.

TradeGate quote and yearly range

TradeGate last showed Sabra at EUR 17.25 on September 25, 2026. The Nasdaq 52-week range was USD 17.17 to USD 22.77 on that date, while market capitalization stood at USD 5.0 billion as of September 28, 2026.